In summary, this study has identified an epigenetic player, HOXB13‐AS1, which was overexpressed in the high‐grade gliomas compared with low‐grade gliomas and normal brain tissues, and upregulation of HOXB13‐AS1 enhanced cell growth and promoted cell cycle progression. This evidence concerns the gene HOXB13 and central nervous system cancer.